Archives
- 2018-07
- 2018-10
- 2018-11
- 2019-04
- 2019-05
- 2019-06
- 2019-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
- 2024-12
- 2025-01
- 2025-02
- 2025-03
-
Pravastatin sodium Chronic hepatitis B virus HBV infection i
2019-06-29
Chronic Pravastatin sodium virus (HBV) infection is prevalent in many Asian countries, notwithstanding three decades of universal hepatitis B vaccination programs. The invention of nucleos(t)ide analogs (NUCs) was a breakthrough in the treatment of chronic hepatitis B (CHB). However, HBV continues
-
At baseline the patient exhibited normal A H
2019-06-29
At baseline, the patient exhibited normal A–H (57ms) and H–V (44ms) intervals, with a sinus BIX 02188 molecular length of 784ms. Both antegrade and retrograde dual atrioventricular (AV) nodal physiologies were assessed by atrial and ventricular extrastimulus (Fig. 2), without inducible AV nodal ree
-
Pharmacokinetics analysis of AT on SCID mice bear http
2019-06-29
Pharmacokinetics analysis of AT-406 on SCID mice bearing MDA-MB-231 tumors has shown that AT-406 achieves a maximum concentration in plasma between 1.5μM and 9.9μM, and a maximum concentration in tumor tissue between 0.5μM and 18.2μM, depending on the dose and administration route (intravenous versu
-
LGX818 what In the phase AZURE trial women were randomly ass
2019-06-29
In the phase 3 AZURE trial, 3360 women were randomly assigned to receive standard adjuvant systemic treatment alone (control group) or with 4mg intravenous zoledronic LGX818 what every 3–4 weeks for 6 doses, then every 3 months for 8 doses, followed by every 6 months for 5 doses, for a total of 5 y
-
Por otra parte en su definici n
2019-06-29
Por otra parte, en su definición experiencial y corporal, estas escenas colocan la Historia verdadera en otra dimensión, el relato de viaje. En efecto, lo que caracterizaría buena parte de esta crónica así como las dos primeras cartas cortesianas (al menos) es el relato del viaje de conquista, el én
-
Gemcitabine molecular En la entrevista a que nos
2019-06-29
En la entrevista Gemcitabine molecular que nos hemos referido, O’Donnell recuerda cómo surgió su interés por los temas referidos a la calidad de la democracia. Señala que quienes habían hecho parte del proyecto de las transiciones, aunque habían incorporado en sus análisis la incertidumbre sobre el
-
Clindamycin Phosphate El reclutamiento era una tarea permane
2019-06-29
El reclutamiento era una tarea permanente de los grupos guerrilleros, en el caso de las mujeres, generalmente mantenían relaciones estrechas con miembros activos de la guerrilla. Hermanos, parientes o amigos sostenían discusiones en el seno familiar sobre las condiciones de injusticia social, repres
-
Data continue to show increasing
2019-06-29
Data continue to show increasing numbers of facility-based deliveries with an appreciable decline in both maternal and newborn baby deaths. With nearly half of all births being delivered in low volume, primary health facilities, these facilities clearly fulfill a very crucial role in ensuring that p
-
Dyslipidemia is characterized by increased total cholesterol
2019-06-29
Dyslipidemia is characterized by increased total cholesterol, LDL-C, and triglyceride levels, and decreased HDL-C levels. However, the association of ApoA1 polymorphism with serum HDL-C level remains controversial. The polymorphisms of ApoA1+84 TC, but not MspI, are associated with serum HDL-C. The
-
br Conclusion br Conflict of interest br Introduction
2019-06-29
Conclusion Conflict of interest Introduction Classically, cancer has been described as a disease involving uncontrolled cell growth. Now, however, it is apparent that cancer growth and metastasis are not solely dependent on the tumor Xylometazoline HCl what themselves, but involve patholog
-
br Case report An year old man
2019-06-29
Case report An 81-year-old man with ischemic cardiomyopathy underwent ICD Cyclo weight for primary prevention in February 2007. The patient had never experienced spontaneous VF. A Riata™ 1570 dual-coiled lead (St. Jude Medical, Sylmar, CA) was passed through the left cephalic vein and connected
-
The circadian variation of VF shows a
2019-06-29
The circadian variation of VF shows a similar nocturnal pattern in patients with BS and ERS [32] (Fig. 2). This is in contrast to the circadian pattern of VTAs in patients with ischemic heart diseases [33]. In a Korean cohort of patients with ERS and BS who underwent implantable cardioverter defibri
-
The very fact that providing a greater number of doses
2019-06-28
The very fact that providing a greater number of doses of IPTp-SP is incrementally effective, even in settings where the parasite is sensitive, also highlights the potential benefit of interventions using more effective drugs. This finding means there is either scope to improve clearance of existing
-
Refametinib br Material and methods br Results
2019-06-28
Material and methods Results Discussion ES-SCLC is a disease with poor prognosis. Treatment outcome has not improved significantly during the last decades despite great efforts have been made. Maintenance therapy has been tried in several clinical trials with the aim to prevent the onset of
-
br Conflict of interest br
2019-06-28
Conflict of interest Introduction Cardiac resynchronization therapy (CRT) has become an important treatment for the management of Miltefosine failure (HF) patients with left ventricular (LV) systolic dysfunction and a ventricular conduction delay [1,2]. Multiple randomized studies have demonst
15621 records 984/1042 page Previous Next First page 上5页 981982983984985 下5页 Last page